Virtual CEU, EBR 2020 Reach Record Breaking Attendance

The Endocrine Society’s first virtual Clinical Endocrinology Update (CEU) and Endocrine Board Review (EBR) meetings collectively attracted more than 1,700 global participants.

CEU 2020 had over 1,100 participants and EBR 2020 has over 600, setting records for both meetings as the largest to date in the Society’s history.

CEU 2020, held September 10-12, provided an update on the latest diagnosis and treatment recommendations spanning nine endocrine topic areas. The virtual meeting featured both live and on-demand presentations. CEU session recordings will be available for purchase within the next three weeks. Highlights from this year include:

  • 23 live sessions with the ability to interact directly with faculty
  • 21 on-demand presentations
  • 31 expert faculty
  • 3 interactive Ancillary Symposia
  • 3 Product Theatre presentations
  • Virtual exhibit hall

Endocrine Board Review takes place from September 16-18. It’s an essential course for endocrinologists preparing to take the boards or practicing physicians seeking an intensive knowledge assessment. The virtual program is designed as a mock exam, and participants can engage directly with the experts during live Q&A.

Registrants can access CEU 2020 and EBR 2020 content in the corresponding virtual meeting platforms through October 31, 2020.

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…

Find more in